The Novel Ocular Drug Delivery Devices Market report features an extensive study of the current market landscape and the likely adoption of novel ocular drug delivery devices, over the next decade. The study features a detailed analysis of the key drivers and trends related to this evolving domain. According to the World Health Organization (WHO), more […]
The surge in demand for COVID-19 vaccines has presented lucrative opportunities for both innovators and contract service providers having continuous and semi-continuous manufacturing capabilities for biointensification London Roots Analysis has announced the addition of “Continuous and Semi-Continuous Bioprocessing Market, 2021 – 2030” report to its list of offerings. Given the growing pipeline
Presently, more than 150 pre-sterilized / RTU primary packaging systems, including cartridges, syringes and vials, as well as their respective closure systems are available worldwide. Majority (50%) of the pre-sterilized / RTU primary packaging systems are closures, followed by containers (34%) and container-closure systems (16%). It is worth highlighting that, of the total, 54 closures
PRE-STERILIZED / READY-TO-USE PRIMARY PACKAGING MARKET – CURRENT MARKET LANDSCAPE Read More »
Given the consistent increase in number of cell therapies being developed and launched, this upcoming therapeutic segment is on its way to becoming one of the highest valued markets within the biopharmaceutical industry London Roots Analysis has announced the addition of “Cell Therapy Manufacturing Market (4th Edition), 2021-2030” report to its list of
The cell therapy manufacturing market is projected to reach USD 14.5 billion by 2030 Read More »
Off-site, modular construction minimizes disruption to building timelines and logistical delays, ensuring systematic delivery of new facilities, this is particularly beneficial within the healthcare industry, where speed, sanitation and sterility are crucial Roots Analysis is pleased to announce the publication of its recent study, titled, “Modular Facilities in Pharmaceutical and Biotechnology Market” The
reg based therapies have become a research hotspot in the field of immunotherapy due to their ability to prevent / delay graft rejection and control autoimmune responses generated post adoptive transfer in vivo Roots Analysis has announced the addition of “Regulatory T-Cell (Tregs) Therapies Market” report to its list of offerings. Given the
Herceptin® sales peaked in 2018, a year before the primary patent covering the drug expired in the US; in order to carve out a share of the associated opportunity, stakeholders in the pharma industry have long been developing follow on products Roots Analysis has announced the addition of the “Herceptin® (Trastuzumab) Biosimilars ” report
With the emergence of blockbuster drugs, such as Gazyva® (for Chronic Lymphocytic Leukemia) and POTELEGIO® (for Sézary syndrome), Fc engineered antibodies have garnered significant interest in the medical community, for various clinical conditions London Roots Analysis has announced the addition of “Fc Protein and Glyco-engineered Antibodies Market2021-2030” report to its list of offerings.
In addition to being a time and cost intensive process, protein engineering is fraught with several challenges; considering the expertise available with protein design and engineering service providers to design novel molecules, drug developers are actively outsourcing their operations Roots Analysis has announced the addition of “Protein Design and Engineering Market” report to its
NGS library preparation kit providers are constantly innovating their products to construct high-quality and efficient nucleotide libraries; the ongoing efforts are to bring a paradigm shift in biomarker research, cancer therapy, diagnostics and personalized medicine Roots Analysis has announced the addition of “Next Generation Sequencing Kits Market, 2021 – 2035” report to its list
